Clinical cure rate of inactive HBsAg carriers with HBsAg
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1091786
Abstract: Purpose HBsAg clearance represents clinical cure for patients with hepatitis B, but remains difficult to obtain for most HBV-infected patients. Recent studies have shown that inactive HBsAg carriers treated with pegylated interferon can achieve higher… read more here.
Keywords: hbsag; hbsag carriers; inactive hbsag; rate ... See more keywords